← FDA DRUG APPROVALS

FDA ANDA · ANDA075483

ENALAPRIL MALEATE

Sponsor: SENORES PHARMS

APPLICATION
ANDA075483
TYPE
ANDA
ORIGINAL APPROVAL
2000-08-22
LATEST ACTION
2015-09-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

ENALAPRIL MALEATEPrescription
ENALAPRIL MALEATE 10MG · TABLET · ORAL
ENALAPRIL MALEATEPrescription
ENALAPRIL MALEATE 2.5MG · TABLET · ORAL
ENALAPRIL MALEATEPrescription
ENALAPRIL MALEATE 20MG · TABLET · ORAL
ENALAPRIL MALEATEPrescription
ENALAPRIL MALEATE 5MG · TABLET · ORAL

Approval history

2015-09-01Labeling · Supplement 15 · standardAP
2015-09-01Labeling · Supplement 14AP
2008-08-14Labeling · Supplement 10AP
2004-09-23Labeling · Supplement 3AP
2000-08-22OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →